Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group (Q77761547)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878934 AND SRC:MED&resulttype=core&format=json

8 December 2019

title

Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878934 AND SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

U Zeymer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878934 AND SRC:MED&resulttype=core&format=json

8 December 2019

U Tebbe

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878934 AND SRC:MED&resulttype=core&format=json

8 December 2019

R v Essen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878934 AND SRC:MED&resulttype=core&format=json

8 December 2019

W Haarmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878934 AND SRC:MED&resulttype=core&format=json

8 December 2019

K L Neuhaus

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878934 AND SRC:MED&resulttype=core&format=json

8 December 2019

language of work or name

English

0 references

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878934 AND SRC:MED&resulttype=core&format=json

8 December 2019

published in

American Heart Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878934 AND SRC:MED&resulttype=core&format=json

8 December 2019

volume

137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878934 AND SRC:MED&resulttype=core&format=json

8 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878934 AND SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

34-38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878934 AND SRC:MED&resulttype=core&format=json

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70457-6

Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70457-6

Frequency of achieving optimal reperfusion with thrombolysis in acute myocardial infarction (analysis of four German multicenter studies).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70457-6

Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70457-6

Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70457-6

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70457-6

Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70457-6

Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70457-6

Dose finding with a novel recombinant plasminogen activator (BM 06.022) in patients with acute myocardial infarction: results of the German Recombinant Plasminogen Activator Study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Kranken

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70457-6

Open, noncontrolled dose-finding study with a novel recombinant plasminogen activator (BM 06.022) given as a double bolus in patients with acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70457-6

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70457-6

Thrombolytic therapy for patients with myocardial infarction presenting after six hours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70457-6

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70457-6

Differences in clot lysis among patients demonstrated in vitro with three thrombolytic agents (tissue-type plasminogen activator, streptokinase and urokinase)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70457-6

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70457-6

Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70457-6

10.1016/S0002-8703(99)70457-6

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878934 AND SRC:MED&resulttype=core&format=json

8 December 2019

1 reference